Stent with embolic protection device benefits high-risk patients

01/17/2012 |

Stenting in combination with an embolic protection device resulted in lower complication rates for high-risk carotid artery disease patients, according to a University of Wisconsin clinical trial. The study was meant to evaluate Emboshield Pro, a device used with stenting to open blocked vessels and capture dislodged plaque. "This is very good news for high-risk patients suffering with carotid artery disease, who only a decade ago had limited treatment options and poor long-term outcomes," said Dr. Jon Matsumura, the lead researcher.

View Full Article in:

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Analyst Compliance
Edwards Lifesciences
Irvine, CA
Legal Counsel
Fort Worth, TX
Director, Senior Legal Counsel
Fort Worth, TX
Corporate Counsel - Healthcare Law Group
South San Francisco, CA
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD